Cargando…
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
BACKGROUND: This study aimed to determine the effectiveness of liquid biopsy in detecting epidermal growth factor receptor (EGFR) mutations at diagnosis, disease progression, and intermediate stages. METHODS: This prospective, multicenter, observational study included 30 patients with non-small cell...
Autores principales: | Fujii, Hiroaki, Nagakura, Hideyuki, Kobayashi, Nobuaki, Kubo, Sousuke, Tanaka, Katsushi, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Nishikawa, Masanori, Miura, Kenji, Koizumi, Harumi, Ito, Yu, Tsubakihara, Motofumi, Miyazawa, Naoki, Kudo, Makoto, Shinkai, Masaharu, Kaneko, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531433/ https://www.ncbi.nlm.nih.gov/pubmed/36192767 http://dx.doi.org/10.1186/s12885-022-10135-z |
Ejemplares similares
-
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
por: Matsumoto, Hiromi, et al.
Publicado: (2021) -
Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
por: Kobayashi, Nobuaki, et al.
Publicado: (2020) -
Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
por: Chen, Hao, et al.
Publicado: (2020) -
Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients
por: Horita, Nobuyuki, et al.
Publicado: (2016) -
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients
por: Tashiro, Ken, et al.
Publicado: (2017)